Showdown Near Between Brazil and AIDS Drugs Labs

    The Brazilian government must soon decide about breaking the patents of three antiretroviral medications that are part of the anti-AIDS cocktail.

    The decision will probably be made as soon as Minister of Health, Humberto Costa, returns from his trip to Africa, where he is accompanying President Luiz Inácio Lula da Silva.


    During this week, the Ministry will still try to negotiate with medicine producers who, almost a month ago, received a government’s request asking for their voluntary license consent, and authorization for the government to produce the medications in Brazil paying for their royalties.


    Without identifying the laboratories, the Minister press-service informed that their answers were not very positive. Two out of the three labs contacted by the Minister accept to negotiate, but not under the government’s terms, and the third one does not agree with the proposal.


    According to the secretary of Health Protection, Jarbas Barbosa, the volume of resources Brazil spends buying antiretrovirals increases to “unbearable” levels. In 2004, the Ministry spent US$ 217 million (560 million reais) with this type of medication.


    According to Barbosa, the government will spend over R$ 349 million (900 million reais) this year, even though the number of new patients has risen only 20%.


    “Looking ahead, in two or three years, the situation may negatively affect Brazilian policy for universal access to antiretroviral medication,” he alerts.


    Brazil produces only eight of the 16 medications that integrate the anti-AIDS cocktail.


    Last March 14th, the Ministry solicited voluntary licensing of three medications: Lopinavir /Ritonavir (Abbot), Efavirenz (Merck Sharp & Dohme), and Tenofovir (Gilead Science Incorporation).


    The Ministry of Health affirms that if the laboratories do not accept the proposal, the country may seek compulsory licensing. This mechanism is allowed by the Trade-Related Aspects of Intellectual Property Rights (TRIPS) for cases involving public health.


    Agência Brasil

    Tags:

    • Show Comments (1)

    Your email address will not be published. Required fields are marked *

    comment *

    • name *

    • email *

    • website *

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    Ads

    You May Also Like

    Brazil's Finance minister, Guido Mantega

    Brazil Hosts G-20 Ministers and Demands more Power for Emerging Countries

    When the ministers of the finance area and governors of central banks of the ...

    5% of Brazil’s GDP Goes on Red Tape and Then You Have Corruption

    A survey by the Rio de Janeiro American Chamber of Commerce, in Brazil, found ...

    Cargo ship

    Brazil Spares World’s Poorest Countries from Import Tariffs

    Since the Doha Round, a negotiation on trade liberalization between developed and developing countries ...

    Brazil’s Lula and Argentina’s Kirchner Talk About Mercosur’s Viability

    The leaders of Argentina and Brazil are meeting in São Paulo, in the Brazilian ...

    Brazil Probes Ozone Layer in Search of Climate Changes Answers

    Today marks the end of an international mission, the Equatorial Large Balloon Campaign (Campanha ...

    TAM’s Jets Back in Brazil from Middle East Will Fly to NY and London

    Brazilian Airline TAM will receive by October three aircraft Airbus A330 that had been ...

    Best-seller Books, Plays and Movies

    Electoral competition and the incentives it unleashes form a key source of the dynamism ...

    São Paulo, Brazil's dance school Pulsarte

    Latin America’s Largest Dance School Is Brainchild of Brazilian Dreamer

    The background noise is the sound of impatient shoes tapping the ground, trying to ...

    How the French Shaped the Man Who Would Be Brazil’s President

    Fernando Henrique Cardoso is from a prominent military family and was raised along Copacabana ...

    Brazil: Landless Are Restless

    A festering situation that so far seems not to have attracted attention internationally is ...